Raymond Prudo-Chlebosz
Director · Akari Therapeutics Plc
- 2024
- Dec 19, 2025
- 2
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Raymond Prudo-Chlebosz files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Hoyoung Huh - $1.50M in AKTX purchases and sales in the last 12 months
- Abizer Gaslightwala - $437K in AKTX purchases and sales in the last 12 months
- Samir Rashmikant Patel - $344K in AKTX purchases and sales in the last 12 months
- Sandip I. Patel - $162K in AKTX purchases and sales in the last 12 months
- Robert B. Bazemore - $62K in AKTX purchases and sales in the last 12 months
- Kameel D. Farag - $10K in AKTX purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Raymond Prudo-Chlebosz?
Raymond Prudo-Chlebosz is a corporate insider, tracked as Director of Akari Therapeutics Plc (AKTX). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Raymond Prudo-Chlebosz last file a Form 4?
The most recent primary Form 4 on record is dated 19 December 2025, one of 2 filings going back to 2024.
Has Raymond Prudo-Chlebosz been buying or selling stock?
Recorded transactions: 4 open-market purchases ($406K) and 0 open-market sales across all tracked filings.
